A decade genetic diversity in Circulating influenza B virus in Iran (2010–2019): Divergence from WHO-recommended vaccine strains
- Authors: Emami A.1, Pirbonyeh N.2, Moattari A.2, Javanmardi F.2
-
Affiliations:
- Shiraz University of medical sciences
- Shiraz University of Medical Sciences
- Issue: Vol 68, No 5 (2023)
- Pages: 385-393
- Section: ORIGINAL RESEARCH
- URL: https://journals.rcsi.science/0507-4088/article/view/231858
- DOI: https://doi.org/10.36233/0507-4088-180
- EDN: https://elibrary.ru/hqrvbk
- ID: 231858
Cite item
Full Text
Abstract
Background. Data on the disease burden and circulation patterns of influenza B virus lineages for Iran are limited.
Objective. This review aims to describe the pattern of influenza B occurrence in Iran, comparing it with the proposed vaccine strains and determining the match and mismatch with the prescribed vaccine annually.
Methods. Various sources were used to retrieve information of the data; such as information from an online search of databases such as FluNet, GISAID, and NCBI. After extracting protein sequence records in GISAID, sequence alignment with vaccine strain and construction of a phylogenetic tree were performed. Subsequently, categories of the registered circulating strains were evaluated for matching with the vaccine strains.
Results. Of the total registered influenza-positive samples, 20.21% were related to influenza B virus. The phylogenic tree was designed based on 43 samples registered in the GISAID database; 76.74 and 23.25% sequences were of Yamagata and Victoria lineages, respectively. The most prevalent influenza B virus strains circulating during the study years belonged to the Yamagata lineage. In general, the match of the influenza B virus predominant circulating strains with administrated vaccines was observed in Iran. However, a high level of mismatch between the vaccine strain and Iranian isolates was identified in 2016‒2017.
Conclusion. The review of match and mismatch in influenza vaccine in order to improve the composition of the prescribed vaccine in each region is very important because the vaccine efficacy decreased when the strain included in vaccine did not match the circulating epidemic strain.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Amir Emami
Shiraz University of medical sciences
Author for correspondence.
Email: emami.microbia@gmail.com
ORCID iD: 0000-0002-4510-1820
Ph.D (Microbiology), Department of Microbiology, Burn & Wound Healing Research Center
Iran, Islamic Republic of, ShirazNeda Pirbonyeh
Shiraz University of Medical Sciences
Email: pirbonyeh@yahoo.com
ORCID iD: 0000-0001-5700-3913
Department of Microbiology, Burn & Wound Healing Research Center, Department of Bacteriology and Virology
Iran, Islamic Republic of, ShirazAfagh Moattari
Shiraz University of Medical Sciences
Email: moattari.a@sums.ac.ir
ORCID iD: 0000-0003-4394-9622
Ph.D. (Bacteriology and Virology), Professor of Medical Virology, Department of Bacteriology and Virology
Iran, Islamic Republic of, ShirazFatemeh Javanmardi
Shiraz University of Medical Sciences
Email: javanmardi.biostat@yahoo.com
ORCID iD: 0000-0001-8841-0861
кандидат наук (биостатистика), кафедра биостатистики
Iran, Islamic Republic of, ShirazReferences
- Chen H., Park S.G., Choi N., Moon J.I., Dang H., Das A., et al. SERS imaging-based aptasensor for ultrasensitive and reproducible detection of influenza virus A. Biosens. Bioelectron. 2020; 167: 112496. https://doi.org/10.1016/j.bios.2020.112496
- Tavakoli F., Moattari A., Shamsi Shahr Abadi M., Kadivar M.R., Khodadad N., Pirbonyeh N., et al. Antigenic variation of the haemagglutinin gene of the influenza A (H1N1) pdm09 virus circulating in Shiraz, February-April 2013. Iran. J. Immunol. 2015; 12(3): 198–208.
- Houser K., Subbarao K. Influenza vaccines: challenges and solutions. Cell Host Microbe. 2015; 17(3): 295–300. https://doi.org/10.1016/j.chom.2015.02.012
- WHO. Influenza (Seasonal). Available at: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
- Kim H., Webster R.G., Webby R.J. Influenza virus: dealing with a drifting and shifting pathogen. Viral Immunol. 2018; 31(2):174–83. https://doi.org/10.1089/vim.2017.0141
- CDC. 2021-2022 U.S. Flu Season: Preliminary In-Season Burden Estimates. Available at: https://www.cdc.gov/flu/about/burden/2021-2022.htm#2021-burden-est
- Gaglani M., Vasudevan A., Raiyani C., Murthy K., Chen W., Reis M., et al. Effectiveness of trivalent and quadrivalent inactivated vaccines against influenza B in the United States, 2011-2012 to 2016-2017. Clin. Infect. Dis. 2021; 72(7): 1147–57. https://doi.org/10.1093/cid/ciaa102
- Paul Glezen W., Schmier J.K., Kuehn C.M., Ryan K.J., Oxford J. The burden of influenza B: a structured literature review. Am. J. Public Health. 2013; 103(3): e43-51. https://doi.org/10.2105/ajph.2012.301137
- Rota P.A., Wallis T.R., Harmon M.W., Rota J.S., Kendal A.P, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology. 1990; 175(1): 59–68. https://doi.org/10.1016/0042-6822(90)90186-u
- McAuley J.L., Gilbertson B.P., Trifkovic S., Brown L.E., McKimm-Breschkin J.L. Influenza virus neuraminidase structure and functions. Front. Microbiol. 2019; 10: 39. https://doi.org/10.3389/fmicb.2019.00039
- Flannery B., Clippard J., Zimmerman R.K., Nowalk M.P., Jackson M.L., Jackson L.A., et al. Early estimates of seasonal influenza vaccine effectiveness – United States, January 2015. MMWR Morb. Mortal. Wkly Rep. 2015; 64(1): 10–5.
- Monto A.S., Petrie J.G. Improving influenza vaccine effectiveness: ways to begin solving the problem. Clin. Infect. Dis. 2019; 69(10): 1824–6. https://doi.org/10.1093/cid/ciz416
- Tricco A.C., Chit A., Soobiah C., Hallett D., Meier G., Chen M.H., et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013; 11: 153. https://doi.org/10.1186/1741-7015-11-153
- Flannery B., Kondor R.J.G., Chung J.R., Gaglani M., Reis M., Zimmerman R.K., et al. Spread of antigenically drifted influenza A (H3N2) viruses and vaccine effectiveness in the United States during the 2018–2019 season. J. Infect. Dis. 2020; 221(1): 8–15. https://doi.org/10.1093/infdis/jiz543
- Paules C.I., Fauci A.S. Influenza vaccines: good, but we can do better. J. Infect. Dis. 2019; 219(Suppl. 1): S1–4. https://doi.org/10.1093/infdis/jiy633
- Update: influenza activity – United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb. Mortal. Wkly Rep. 2011; 60(21): 705–12.
- Jackson D., Elderfield R.A., Barclay W.S. Molecular studies of influenza B virus in the reverse genetics era. J. Gen. Virol. 2011; 92(Pt. 1): 1–17. https://doi.org/10.1099/vir.0.026187-0
- Lee Y., Kim K., Ko E., Lee Y., Kim M., Kwon Y., et al. New vaccines against influenza virus. Clin. Exp. Vaccine Res. 2014; 3(1): 12–28. https://doi.org/10.7774/cevr.2014.3.1.12
- Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep. 2009; 58(RR-10): 1–8.
- Puzelli S., Di Martino A., Facchini M., Fabiani C., Calzoletti L., Di Mario G., et al. Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004–2017. BMC Infect. Dis. 2019; 19(1): 990. https://doi.org/10.1186/s12879-019-4621-z
- WHO Expert Committee on Biological Standardization: Fifty-fourth Report; 2005.
- Skowronski D., Masaro C., Kwindt T., Mak A., Petric M., Li Y., et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007; 25(15): 2842–51. https://doi.org/10.1016/j.vaccine.2006.10.002
- Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007; 25(39-40): 6852–62. https://doi.org/10.1016/j.vaccine.2007.07.027
- Luna E.J.A., Gattás V.L., Campos S.R.S.L.C. Effectiveness of the Brazilian influenza vaccination policy: a systematic review. Epidemiol. Serv. Saúde. 2014; 23(3): 559–75. https://doi.org/10.5123/S1679-49742014000300020
- Olsen S.J., Azziz-Baumgartner E., Budd A.P., Brammer L., Sullivan S., Pineda R.F., et al. Decreased influenza activity during the COVID-19 pandemic – United States, Australia, Chile, and South Africa, 2020. Am. J. Transplant. 2020; 20(12): 3681–5. https://doi.org/10.1111/ajt.16381
- Barros E.N., Cintra O., Rossetto E., Freitas L., Colindres R. Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition. Braz. J. Infect. Dis. 2016; 20(1): 81–90. https://doi.org/10.1016/j.bjid.2015.09.009
- Okoli G.N., Racovitan F., Righolt C.H., Mahmud S.M. Variations in seasonal influenza vaccine effectiveness due to study characteristics: a systematic review and meta-analysis of test-negative design studies. Open Forum Infect. Dis. 2020; 7(7): ofaa177. https://doi.org/10.1093/ofid/ofaa177